|
| Exchange Disseminated Time | Panacea Biotec Ltd has informed BSE regarding "WHO delist Company's OPV from its prequalified vaccines list".
Announcement:
"After a site audit of the Oral Polio Vaccine (OPV) manufacturing facility at New Delhi, the Company had undertaken several measures regarding refurbishment of the facility and strengthening of QMS from September to December, 2011. WHO team visited manufacturing facility, Okhla, New Delhi from 3rd January to 1st February 2012 to assess the GMP compliance and the quality management systems applied to production and control of oral polio vaccines." (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|